Research Portal

Warfarin pharmacogenetics: Economic considerations.

Research output: Contribution to journal › Article › peer-review

Standard Standard

Warfarin pharmacogenetics: Economic considerations. / Hughes, D.; Hughes, D.A.; Pirmohamed, M.
In: Pharmacoeconomics, Vol. 25, No. 11, 01.01.2007, p. 899-902.

Research output: Contribution to journal › Article › peer-review

HarvardHarvard

Hughes, D, Hughes, DA & Pirmohamed, M 2007, 'Warfarin pharmacogenetics: Economic considerations.', Pharmacoeconomics, vol. 25, no. 11, pp. 899-902.

APA

Hughes, D., Hughes, D. A., & Pirmohamed, M. (2007). Warfarin pharmacogenetics: Economic considerations. Pharmacoeconomics, 25(11), 899-902.

CBE

Hughes D, Hughes DA, Pirmohamed M. 2007. Warfarin pharmacogenetics: Economic considerations. Pharmacoeconomics. 25(11):899-902.

MLA

Hughes, D., D.A. Hughes and M. Pirmohamed. "Warfarin pharmacogenetics: Economic considerations.". Pharmacoeconomics. 2007, 25(11). 899-902.

VancouverVancouver

Hughes D, Hughes DA, Pirmohamed M. Warfarin pharmacogenetics: Economic considerations. Pharmacoeconomics. 2007 Jan 1;25(11):899-902.

Author

Hughes, D. ; Hughes, D.A. ; Pirmohamed, M. / Warfarin pharmacogenetics: Economic considerations. In: Pharmacoeconomics. 2007 ; Vol. 25, No. 11. pp. 899-902.

RIS

TY - JOUR

T1 - Warfarin pharmacogenetics: Economic considerations.

AU - Hughes, D.

AU - Hughes, D.A.

AU - Pirmohamed, M.

PY - 2007/1/1

Y1 - 2007/1/1

KW - PHARMACOLOGY & PHARMACY

M3 - Article

VL - 25

SP - 899

EP - 902

JO - Pharmacoeconomics

JF - Pharmacoeconomics

SN - 1170-7690

IS - 11

ER -